153 related articles for article (PubMed ID: 9225065)
61. Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.
Warren BS; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Nov; 48(21):5984-8. PubMed ID: 3167850
[TBL] [Abstract][Full Text] [Related]
62. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
63. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
Kraft AS; Smith JB; Berkow RL
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1334-8. PubMed ID: 3456591
[TBL] [Abstract][Full Text] [Related]
64. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S
Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
[TBL] [Abstract][Full Text] [Related]
65. The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2.
Garcia CS; Curiel RE; Mwatibo JM; Pestka S; Li H; Espinoza-Delgado I
J Immunol; 2006 Aug; 177(4):2707-16. PubMed ID: 16888033
[TBL] [Abstract][Full Text] [Related]
66. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
67. In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.
Berkow RL; Schlabach L; Dodson R; Benjamin WH; Pettit GR; Rustagi P; Kraft AS
Cancer Res; 1993 Jun; 53(12):2810-5. PubMed ID: 8504423
[TBL] [Abstract][Full Text] [Related]
68. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
Kraft AS; Baker VV; May WS
Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
[TBL] [Abstract][Full Text] [Related]
69. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
[TBL] [Abstract][Full Text] [Related]
70. Expression of the jun-B gene during induction of monocytic differentiation.
Datta R; Sherman ML; Stone RM; Kufe D
Cell Growth Differ; 1991 Jan; 2(1):43-9. PubMed ID: 2007095
[TBL] [Abstract][Full Text] [Related]
71. Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA.
Pierce JH; Di Marco E; Cox GW; Lombardi D; Ruggiero M; Varesio L; Wang LM; Choudhury GG; Sakaguchi AY; Di Fiore PP
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5613-7. PubMed ID: 2165597
[TBL] [Abstract][Full Text] [Related]
72. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
Jones RJ; Sharkis SJ; Miller CB; Rowinsky EK; Burke PJ; May WS
Blood; 1990 Mar; 75(6):1319-23. PubMed ID: 2310830
[TBL] [Abstract][Full Text] [Related]
73. Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10.
Rieser C; Ramoner R; Böck G; Deo YM; Höltl L; Bartsch G; Thurnher M
Eur J Immunol; 1998 Aug; 28(8):2283-8. PubMed ID: 9710206
[TBL] [Abstract][Full Text] [Related]
74. Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administration.
Bear HD; McFadden AW; Kostuchenko PJ; Lipshy KA; Hamad GG; Turner AJ; Roberts JD; Carr M; Carr S; Grant S
Anticancer Drugs; 1996 May; 7(3):299-306. PubMed ID: 8792004
[TBL] [Abstract][Full Text] [Related]
75. Protein kinase C-alpha and -beta play antagonistic roles in the differentiation process of THP-1 cells.
Dieter P; Schwende H
Cell Signal; 2000 May; 12(5):297-302. PubMed ID: 10822170
[TBL] [Abstract][Full Text] [Related]
76. Induction of apoptosis and differentiation by fludarabine in human leukemia cells (U937): interactions with the macrocyclic lactone bryostatin 1.
Vrana JA; Wang Z; Rao AS; Tang L; Chen JH; Kramer LB; Grant S
Leukemia; 1999 Jul; 13(7):1046-55. PubMed ID: 10400420
[TBL] [Abstract][Full Text] [Related]
77. The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with recombinant murine granulocyte-macrophage colony-stimulating factor, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation.
Grant S; Traylor R; Pettit GR; Lin PS
Blood; 1994 Feb; 83(3):663-7. PubMed ID: 8298128
[TBL] [Abstract][Full Text] [Related]
78. The clinical development of the bryostatins.
Clamp A; Jayson GC
Anticancer Drugs; 2002 Aug; 13(7):673-83. PubMed ID: 12187323
[TBL] [Abstract][Full Text] [Related]
79. A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation.
Cabodi S; Calautti E; Talora C; Kuroki T; Stein PL; Dotto GP
Mol Cell; 2000 Nov; 6(5):1121-9. PubMed ID: 11106751
[TBL] [Abstract][Full Text] [Related]
80. Monoclonal antibody binding to a receptor on nonspecific cytotoxic cells (NCC) increases the expression of proto-oncogene kinases and protein kinase C.
Jaso-Friedmann L; Leary JH; Evans DL
Cell Signal; 1995 Jul; 7(5):463-70. PubMed ID: 8562307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
